10-Q Filing

Dominari Holdings Inc. CIK: 12239 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001213900-20-012254`
Period End Date	20200331
Filing Date	20200514
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	alki-20200331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 24 Cash Flow Statement 55 Stockholders Equity 14

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$252.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$446.00K	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$857.00K	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$16.14M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$181.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$165.00K	USD	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$16.56M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.13M	USD	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	20.86M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	20.86M	shares	Point-in-time
Investments	`Investments`	$10.15M	USD	Point-in-time
Investments	`Investments`	$5.03M	USD	Point-in-time
Total assets	`Assets`	$11.28M	USD	Point-in-time
Total assets	`Assets`	$21.59M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	4.83M	shares	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	4.83M	shares	Point-in-time
Treasury stock	`TreasuryStockShares`	3.00	shares	Point-in-time
Treasury stock	`TreasuryStockShares`	3.00	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$68.00K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$177.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$682.00K	USD	Point-in-time
Accrued salaries and benefits	`EmployeeRelatedLiabilitiesCurrent`	$438.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$750.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$615.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$615.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$750.00K	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 20,857,912 and 4,825,552 shares issued at March 31, 2020 and December 31, 2019, respectively; 20,857,909 and 4,825,549 shares outstanding at March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value, 100,000,000 shares authorized; 20,857,912 and 4,825,552 shares issued at March 31, 2020 and December 31, 2019, respectively; 20,857,909 and 4,825,549 shares outstanding at March 31, 2020 and December 31, 2019, respectively	`CommonStockValue`	$2.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$173.84M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapital`	$155.06M	USD	Point-in-time
Treasury stock, at cost, 3 shares at March 31, 2020 and December 31, 2019	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Treasury stock, at cost, 3 shares at March 31, 2020 and December 31, 2019	`TreasuryStockValue`	$264.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-152.60M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-144.27M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.98M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.53M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.98M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.10M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$11.28M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$21.59M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.30M	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$713.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$85.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	-	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	-	USD	1 Quarter
Research and development - license acquired	`ResearchAndDevelopmentLicenseAcquired`	$1.01M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.40M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$713.00K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-713.00K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.40M	USD	1 Quarter
Gains and (losses) on marketable securities	`MarketableSecuritiesGainLoss`	$-863.00K	USD	1 Quarter
Gains and (losses) on marketable securities	`MarketableSecuritiesGainLoss`	$92.00K	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-5.07M	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-475.00K	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentOfWarrants`	$53.00K	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-5.93M	USD	1 Quarter
Total other expenses	`NonoperatingIncomeExpense`	$-436.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.15M	USD	1 Quarter
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.91	USD	1 Quarter
Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.57	USD	1 Quarter
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.20M	shares	1 Quarter
Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.01M	shares	1 Quarter

Cash Flow Statement 55 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-8.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.15M	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-5.07M	USD	1 Quarter
Change in fair value of investment	`GainLossOnInvestments`	$-475.00K	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentsForWarrantLiabilities`	$-53.00K	USD	1 Quarter
Change in fair value of warrant liabilities	`FairValueAdjustmentsForWarrantLiabilities`	-	USD	1 Quarter
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	$1.01M	USD	1 Quarter
Research and development-acquired license, expensed	`ResearchAndDevelopmentacquiredLicenseExpensed`	-	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$6.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	-	USD	1 Quarter
Realized loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-73.00K	USD	1 Quarter
Realized loss on marketable securities	`MarketableSecuritiesRealizedGainLoss`	$-44.00K	USD	1 Quarter
Unrealized loss (gain) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$148.00K	USD	1 Quarter
Unrealized loss (gain) on marketable securities	`MarketableSecuritiesUnrealizedGainLoss`	$-835.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-18.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-16.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$102.00K	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-10.00K	USD	1 Quarter
Accrued salaries and benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-84.00K	USD	1 Quarter
Accrued salaries and benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-244.00K	USD	1 Quarter
Payable to DatChat	`IncreaseDecreaseInPayableToDatchat`	$-50.00K	USD	1 Quarter
Payable to DatChat	`IncreaseDecreaseInPayableToDatchat`	$130.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-896.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.45M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$2.85M	USD	1 Quarter
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$20.38M	USD	1 Quarter
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$4.37M	USD	1 Quarter
Sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$4.21M	USD	1 Quarter
Purchase of investments at fair value	`PaymentsToAcquireInvestments`	-	USD	1 Quarter
Purchase of investments at fair value	`PaymentsToAcquireInvestments`	$200.00K	USD	1 Quarter
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	$1.01M	USD	1 Quarter
Purchase of research and development licenses	`PaymentsToAcquireInProcessResearchAndDevelopment`	-	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.32M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.17M	USD	1 Quarter
Proceeds from issuance common stock, common warrants and prefunded warrants, net of offering cost	`ProceedsFromIssuanceCommonStockCommonWarrantsAndPrefundedWarrantsNetOfOfferingCost`	-	USD	1 Quarter
Proceeds from issuance common stock, common warrants and prefunded warrants, net of offering cost	`ProceedsFromIssuanceCommonStockCommonWarrantsAndPrefundedWarrantsNetOfOfferingCost`	$6.55M	USD	1 Quarter
Proceeds from issuance common stock, net of offering cost	`ProceedsFromIssuanceOfCommonStock`	$2.00M	USD	Point-in-time
Proceeds from issuance common stock, net of offering cost	`ProceedsFromIssuanceOfCommonStock`	-	USD	1 Quarter
Proceeds from issuance common stock, net of offering cost	`ProceedsFromIssuanceOfCommonStock`	$5.09M	USD	1 Quarter
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	1 Quarter
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$7.14M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$18.78M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$161.00K	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$424.00K	USD	1 Quarter
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$252.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$22.00K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$446.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$252.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$91.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$22.00K	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$446.00K	USD	Point-in-time
Offering cost included in accrued expenses	`OfferingCostIncludedInAccruedExpenses`	-	USD	1 Quarter
Offering cost included in accrued expenses	`OfferingCostIncludedInAccruedExpenses`	$7.00K	USD	1 Quarter

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$20.98M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$20.98M	USD	Point-in-time
Balance	`StockholdersEquity`	$12.10M	USD	Point-in-time
Issuance of common stock and prefunded common stock warrants, net of offering cost	`StockIssuedDuringPeriodValueNewIssues2`	$6.54M	USD	1 Quarter
Issuance of common stock, net of offering cost / At-the-market offering	`StockIssuedDuringPeriodValueNewIssues`	$5.09M	USD	1 Quarter
Common warrant and prefunded warrant exercise	`StockIssuedDuringPeriodValueOfCommonWarrantAndPrefundedWarrantExercise`	$7.14M	USD	1 Quarter
Stock-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$6.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.33M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.15M	USD	1 Quarter
Balance	`StockholdersEquity`	$20.98M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.53M	USD	Point-in-time
Balance	`StockholdersEquity`	$20.98M	USD	Point-in-time
Balance	`StockholdersEquity`	$12.10M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.